Korean biotech company CTCBIO said Friday it had sealed a deal with two organizations in the Middle East and Africa to provide sell its erectile dysfunction products in the regions.

CTCBIO will provide Tadalafil (original: Cialis) and Sildenafil (original: Viagra) to countries in the Gulf Cooperation Council (GCC) and the Middle East and North Africa (MENA) region, it said.

“Following the agreements signed with foreign pharmaceuticals like Abbott within the last couple of years, we have expanded our sales area to the Middle East and Africa through this contract,” CTCBIO CEO Sung Ki-hong said. “We will work towards gaining licensing and sales rights in Asia and South America starting next year.”

CTCBIO operates in the pharmaceutical, functional food and animal health businesses and has overseas branches in the U.S., Vietnam, China, and Australia, the company said.